Bangkok Dusit Medical Services Public Company Limited
BDUUY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $28,242,726 | $26,727,423 | $28,083,927 | $27,403,702 |
| % Growth | 5.7% | -4.8% | 2.5% | – |
| Cost of Goods Sold | $17,791,633 | $17,335,359 | $17,685,855 | $17,037,258 |
| Gross Profit | $10,451,093 | $9,392,064 | $10,398,072 | $10,366,444 |
| % Margin | 37% | 35.1% | 37% | 37.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5,372,052 | $5,323,324 | $5,152,930 | $5,476,172 |
| SG&A Expenses | $5,372,052 | $5,323,324 | $5,152,930 | $5,476,172 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$374,244 | -$434,162 | -$378,067 | -$433,777 |
| Operating Expenses | $4,997,808 | $4,889,162 | $4,774,863 | $5,042,395 |
| Operating Income | $5,453,285 | $4,502,902 | $5,623,209 | $5,324,049 |
| % Margin | 19.3% | 16.8% | 20% | 19.4% |
| Other Income/Exp. Net | -$26,749 | -$49,327 | -$47,134 | -$43,684 |
| Pre-Tax Income | $5,426,536 | $4,453,575 | $5,576,075 | $5,280,364 |
| Tax Expense | $972,901 | $835,549 | $1,080,847 | $840,596 |
| Net Income | $4,319,072 | $3,489,918 | $4,346,435 | $4,332,600 |
| % Margin | 15.3% | 13.1% | 15.5% | 15.8% |
| EPS | 10.8 | 8.8 | 10.8 | 10.8 |
| % Growth | 22.7% | -18.5% | 0% | – |
| EPS Diluted | 10.8 | 8.8 | 10.8 | 10.8 |
| Weighted Avg Shares Out | 397,300 | 397,300 | 397,300 | 397,300 |
| Weighted Avg Shares Out Dil | 397,300 | 397,300 | 397,300 | 397,300 |
| Supplemental Information | – | – | – | – |
| Interest Income | $25,812 | $33,618 | $31,396 | $39,022 |
| Interest Expense | $79,324 | $96,362 | $97,118 | $107,867 |
| Depreciation & Amortization | $1,758,788 | $1,659,045 | $1,622,335 | $1,604,705 |
| EBITDA | $7,264,648 | $6,208,982 | $7,295,528 | $6,992,936 |
| % Margin | 25.7% | 23.2% | 26% | 25.5% |